J. Offenberger

440 total citations
6 papers, 250 citations indexed

About

J. Offenberger is a scholar working on Genetics, Pathology and Forensic Medicine and Nutrition and Dietetics. According to data from OpenAlex, J. Offenberger has authored 6 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 2 papers in Pathology and Forensic Medicine and 2 papers in Nutrition and Dietetics. Recurrent topics in J. Offenberger's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Autoimmune Bullous Skin Diseases (2 papers) and HIV Research and Treatment (1 paper). J. Offenberger is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Autoimmune Bullous Skin Diseases (2 papers) and HIV Research and Treatment (1 paper). J. Offenberger collaborates with scholars based in United States, Switzerland and Germany. J. Offenberger's co-authors include Warren M. Gold, Donald G. Payan, E J Goetzl, J.G. Dohlman, Michael Y. Wong, C. M. Kirsch, Lynda C. Schneider, Kraig W. Jacobson, Anthony B. Minnefor and James M. Oleske and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, The Journal of Pediatrics and Allergy.

In The Last Decade

J. Offenberger

6 papers receiving 240 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Offenberger United States 4 104 92 53 44 40 6 250
Jim Christensen United States 6 102 1.0× 19 0.2× 15 0.3× 187 4.3× 34 0.8× 7 308
R. Faraawi Canada 7 44 0.4× 29 0.3× 6 0.1× 44 1.0× 50 1.3× 12 182
Gloria Pérez‐Rus Spain 7 54 0.5× 17 0.2× 10 0.2× 26 0.6× 105 2.6× 14 214
J.A. Carneros Spain 6 48 0.5× 24 0.3× 10 0.2× 20 0.5× 95 2.4× 17 343
Didier Reijasse France 6 15 0.1× 35 0.4× 10 0.2× 7 0.2× 25 0.6× 7 189
Junnosuke Watanabe Japan 7 29 0.3× 11 0.1× 72 1.4× 36 0.8× 68 1.7× 10 480
Malai Wongchanchailert Thailand 11 167 1.6× 7 0.1× 62 1.2× 21 0.5× 172 4.3× 34 350
Werviston De Faria United States 10 8 0.1× 128 1.4× 21 0.4× 13 0.3× 15 0.4× 19 373
Iwona Domżalska-Popadiuk Poland 9 30 0.3× 39 0.4× 17 0.3× 4 0.1× 49 1.2× 19 261
Luciana Tucunduva Brazil 11 43 0.4× 9 0.1× 27 0.5× 7 0.2× 181 4.5× 27 282

Countries citing papers authored by J. Offenberger

Since Specialization
Citations

This map shows the geographic impact of J. Offenberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Offenberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Offenberger more than expected).

Fields of papers citing papers by J. Offenberger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Offenberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Offenberger. The network helps show where J. Offenberger may publish in the future.

Co-authorship network of co-authors of J. Offenberger

This figure shows the co-authorship network connecting the top 25 collaborators of J. Offenberger. A scholar is included among the top collaborators of J. Offenberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Offenberger. J. Offenberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Craig, Timothy, Againdra K. Bewtra, Sami L. Bahna, et al.. (2011). C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks - final results of the I.M.P.A.C.T.2 study. Allergy. 66(12). 1604–1611. 104 indexed citations
2.
Goodman, Susan M., Robyn J. Levy, Againdra K. Bewtra, et al.. (2010). C1 Esterase Inhibitor (C1-INH) Concentrate in the Treatment of Acute Attacks in Hereditary Angioedema: Interim Results of the Treatment of 975 Attacks in an Ongoing, Prospective, Open-Label Study in North America (I.M.P.A.C.T.2). Journal of Allergy and Clinical Immunology. 125(2). AB166–AB166. 2 indexed citations
3.
Wasserman, Richard L., Againdra K. Bewtra, James N. Moy, et al.. (2009). C1 Esterase Inhibitor Concentrate (C1-INH) for the Treatment of Acute Attacks of Hereditary Angioedema: Interim Results of an Ongoing, Prospective, Open Label Study in North America after 640 attacks (I.M.P.A.C.T.2). Journal of Allergy and Clinical Immunology. 123(2). S99–S99. 3 indexed citations
4.
Gupta, Suresh, Vijay V. Joshi, Frederick J. DiCarlo, et al.. (1988). Acquired immunodeficiency syndrome-associated renal disease in children. The Journal of Pediatrics. 113(1). 39–44. 55 indexed citations
5.
Kirsch, C. M., Donald G. Payan, Michael Y. Wong, et al.. (1988). Effect of eicosapentaenoic acid in asthma. Clinical & Experimental Allergy. 18(2). 177–187. 78 indexed citations
6.
Offenberger, J., Tracy A. Lieu, Oscar L. Frick, & Arthur J. Ammann. (1986). Impaired monocyte-to-macrophage maturation in patients with lymphadenopathy syndrome. Journal of Clinical Immunology. 6(6). 467–471. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026